Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Montelukast 10 mg Tablet vs Singulair 10 mg Film-Coated Tablet under fasting in healthy Thai volunteers
TCTR20201006002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by Bio-innova. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20201006002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201006002.